{{Rsnum
|rsid=7147996
|Gene=EFCAB11
|Chromosome=14
|position=89930230
|Orientation=plus
|GMAF=0.2957
|Gene_s=EFCAB11
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 20.6 | 55.1 | 24.3
| HCB | 3.0 | 28.6 | 68.4
| JPT | 1.8 | 39.6 | 58.6
| YRI | 1.4 | 9.0 | 89.7
| ASW | 1.8 | 27.3 | 70.9
| CHB | 3.0 | 28.6 | 68.4
| CHD | 1.8 | 27.5 | 70.6
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 14.7 | 85.3
| MEX | 7.0 | 33.3 | 59.6
| MKK | 2.0 | 19.7 | 78.3
| TSI | 17.2 | 50.5 | 32.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=6E-6
  |OR=28.09
  |ORtxt=[15.96-40.22] mg/dL decrease
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}